Robert D. Hardie

Insider Reports History

Location
210 Ridge Mcintire Road, Suite 350, Charlottesville, VA
Signature
/s/ Katherine Denby, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert D. Hardie:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Acumen Pharmaceuticals, Inc. 10%+ Owner Common Stock 658K $2.28M $3.47 Jul 6, 2021 Indirect
Acumen Pharmaceuticals, Inc. 10%+ Owner Series A-1 Preferred Stock 0 Jul 6, 2021 Indirect
Acumen Pharmaceuticals, Inc. 10%+ Owner Series B Preferred Stock 0 Jul 6, 2021 Indirect

Insider Reports Filed by Robert D. Hardie

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ABOS Acumen Pharmaceuticals, Inc. Jul 6, 2021 6 $5M 4 Jul 8, 2021 10%+ Owner
ABOS Acumen Pharmaceuticals, Inc. Jul 6, 2021 5 $12M 4 Jul 8, 2021 10%+ Owner
ABOS Acumen Pharmaceuticals, Inc. Jun 30, 2021 0 $0 3 Jun 30, 2021 10%+ Owner